No Photo Available

Last Update

2016-11-18T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Herbert Nagasawa?

Dr. Herbert T. Nagasawa

Executive Scientist

Max International LLC

HQ Phone: (801) 316-6380

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Max International LLC

6965 S Union Park Center Suite 100

Salt Lake City, Utah 84047

United States

Company Description

Max International is dedicated to improving everyday lives. This commitment can be seen in everything we do, from our superior products to the charity events we organize around the world. This isn't some newfound mission; it's been our focus from Day 1. ... more

Find other employees at this company (496)

Background Information

Employment History

Principal Scientist

VA Medical Center

Visiting Professor

Washington State University

Ad Hoc Grant Reviewer

NIAAA

Ad Hoc Grant Reviewer

NCI Building Systems , Inc.

Affiliations

Post-doctoral Fellow In Biochemistry
University of Minnesota

Founder
NEW Technology

Education

National Institutes of Health-Homeland Security 4th Annual Countermeasures Against Chemical Threats Network Symposium

B.S. degree

chemistry

Western Reserve University

Ph.D.

Ph.D. degree

organic chemistry

University of Minnesota

Ph.D.'s RiboCeine invention

Web References (200 Total References)


Max International

maxgxl.com [cached]

RiboCeine was developed by the world-renowned research scientist and medicinal chemist, Herbert T. Nagasawa, Ph.D. Dr. Nagasawa was a Professor of Medicinal Chemistry and Toxicology at the University of Minnesota for forty years and at the same time he was named Senior Career Research Scientist for the Veterans Administration in Minneapolis. For thirty-two of those years he was Senior Editor of the Journal of Medicinal Chemistry. Dr. Nagasawa now serves as the Executive Scientist for Max International.


Max International

max4u.com [cached]

RiboCeine was developed by the world-renowned research scientist and medicinal chemist, Herbert T. Nagasawa, Ph.D. Dr. Nagasawa was a Professor of Medicinal Chemistry and Toxicology at the University of Minnesota for forty years and at the same time he was named Senior Career Research Scientist for the Veterans Administration in Minneapolis. For thirty-two of those years he was Senior Editor of the Journal of Medicinal Chemistry. Dr. Nagasawa now serves as the Executive Scientist for Max International.


Max International

max4u.com [cached]

Although Max was founded only in 2007, our growing expertise is based on more than 25 years of research performed by Dr. Herbert Nagasawa, who joined Max in 2009.

...
Dr. Herbert T. Nagasawa, Executive Research Scientist Dr. Nagasawa received his B.S. degree in chemistry from Western Reserve University (now, Case-Western Reserve) in Cleveland, Ohio, and a Ph.D. degree in organic chemistry from the University of Minnesota. Subsequently, he spent two years as a Post-doctoral Fellow in biochemistry at the University of Minnesota before joining the research staff of the V.A. Medical Center in Minneapolis as a Senior Chemist. He was appointed Assistant Professor of Medicinal Chemistry at the University of Minnesota in 1959. He was named Principal Scientist of the VAMC in 1961 and was promoted in 1976 to Senior Research Career Scientist, a nationwide VA title reserved for the VA's top scientists. He was promoted to Associate Professor in 1963 and to Professor of Medicinal Chemistry in 1973. He also held joint professorships in the Department of Pharmacology and the university-wide Division of Toxicology, and served as Visiting Professor at Washington State University in 1990. He also served for 32 years as a Senior Editor for the prestigious international Journal of Medicinal Chemistry from 1972 to 2004, and one year as Acting Editor-in-Chief. In addition, he served on the Editorial Board of the journal, Bioconjugate Chemistry for eight years, and as an ad hoc grant reviewer for the NCI and NIAAA, National Institutes of Health. He has published over 165 papers in peer-reviewed journals. In June of 2010, Herb attended the National Institutes of Health-Homeland Security 4th Annual Countermeasures Against Chemical Threats Network Symposium held in San Francisco. Herb and the team of scientists presented their work on the cyanide antidote.
...
Scott, an original co-founder of CellGevity, then left to join Dr. Herb Nagasawa and Scott Momii at CellGevity, and served full-time as the Chief Technical Officer (CTO).


Max International

maxgxl.com [cached]

RiboCeine was developed by the world-renowned research scientist and medicinal chemist, Herbert T. Nagasawa, Ph.D. Dr. Nagasawa was a Professor of Medicinal Chemistry and Toxicology at the University of Minnesota for forty years and at the same time he was named Senior Career Research Scientist for the Veterans Administration in Minneapolis. For thirty-two of those years he was Senior Editor of the Journal of Medicinal Chemistry. Dr. Nagasawa now serves as the Executive Scientist for Max International.


Max International

max4u.com [cached]

Although Max was founded only in 2007, our growing expertise is based on more than 25 years of research performed by Dr. Herbert Nagasawa, who joined Max in 2009.

...
Dr. Herbert T. Nagasawa, Executive Research Scientist Dr. Nagasawa received his B.S. degree in chemistry from Western Reserve University (now, Case-Western Reserve) in Cleveland, Ohio, and a Ph.D. degree in organic chemistry from the University of Minnesota. Subsequently, he spent two years as a Post-doctoral Fellow in biochemistry at the University of Minnesota before joining the research staff of the V.A. Medical Center in Minneapolis as a Senior Chemist. He was appointed Assistant Professor of Medicinal Chemistry at the University of Minnesota in 1959. He was named Principal Scientist of the VAMC in 1961 and was promoted in 1976 to Senior Research Career Scientist, a nationwide VA title reserved for the VA's top scientists. He was promoted to Associate Professor in 1963 and to Professor of Medicinal Chemistry in 1973. He also held joint professorships in the Department of Pharmacology and the university-wide Division of Toxicology, and served as Visiting Professor at Washington State University in 1990. He also served for 32 years as a Senior Editor for the prestigious international Journal of Medicinal Chemistry from 1972 to 2004, and one year as Acting Editor-in-Chief. In addition, he served on the Editorial Board of the journal, Bioconjugate Chemistry for eight years, and as an ad hoc grant reviewer for the NCI and NIAAA, National Institutes of Health. He has published over 165 papers in peer-reviewed journals. In June of 2010, Herb attended the National Institutes of Health-Homeland Security 4th Annual Countermeasures Against Chemical Threats Network Symposium held in San Francisco. Herb and the team of scientists presented their work on the cyanide antidote.
...
Scott, an original co-founder of CellGevity, then left to join Dr. Herb Nagasawa and Scott Momii at CellGevity, and served full-time as the Chief Technical Officer (CTO).

Similar Profiles

Other People with this Name

Other people with the name Nagasawa

Yoshikazu Nagasawa
pH-QUEST

Takako Nagasawa
Sotheby's

Kazuya Nagasawa
Novartis AG

Laura Nagasawa
First Hawaiian Bank

Mark Nagasawa
Erikson Institute

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory